Recently, there have been several studies on the effects of S-1 in bladder cancer, in particular with a high level of DPD on the basis of the fact that S-1 has the strongest DPD inhibitor among 5-FU-related agents 8–21. The gene discussed is PSMD1; the disease is urinary bladder carcinoma.